Commodity Chemicals
54 companies listed on NSE in this sector
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Consolidated operating income grew 33.7% YoY to INR 108.3 Cr in FY2025 from INR 81.0 Cr in FY2024. Standalone Q4 FY24 income grew 4% YoY to INR 108 Cr.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
The company operates in a single business segment: high purity Aluminium Fluoride (AlF3). Segment-specific revenue growth was not explicitly disclosed, but the Operating Profit rat...
Not disclosed in available documents, though operating margins for the Oxo Alcohols segment declined in FY2025 and Q1FY2026 due to global pricing pressure.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Formaldehyde is the primary revenue contributor following a capacity enhancement in FY24. While specific segment growth percentages are not disclosed, the company maintains a total...
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Not disclosed in available documents. The company operates in the agro-trading segment including spices, oil seeds, grains, and vegetables, but specific YoY growth percentages for ...
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
No documents found
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
No documents found
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Standalone revenue from operations grew 18.75% YoY, increasing from INR 131.16 Cr in FY24 to INR 155.75 Cr in FY25. Segment-specific growth percentages are not disclosed in availab...
No documents found
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
No documents found
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
The company achieved a total revenue of INR 1,450.10 Cr in FY25, growing 29.42% YoY. The Metal segment grew 42.38% to INR 1,087.55 Cr, Metallic Oxides grew 12.70% to INR 421.75 Cr,...
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Revenue from operations reached INR 707.4 Cr in FY23, representing a 56% YoY growth. In FY25, the company reported a further ~35% YoY growth in the scale of operations, driven by i...
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
No documents found
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Total operating income grew 13.1% from INR 1,545.96 Cr in FY24 to INR 1,749.04 Cr in FY25. H1FY26 revenue reached INR 990.88 Cr, a 12% YoY increase compared to H1FY25.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
No documents found
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Not disclosed in available documents.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Total revenue grew 3.45% YoY from INR 126.40 Cr to INR 130.75 Cr. The company operates primarily in a single business segment: Chemicals.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
Investment analysis available. Click to view detailed financial performance, growth strategy, and risk assessment.
